PTGS2 and cancer: The Cyclooxygenase 2 (COX-2) is an inducible enzyme that is over-expressed in tumor cells and is known to induce tumor growth in different types of cancers, so delivery of COX-2 inhibitors has a potential role in decreasing tumor progression in SCC [4,5].